Blood test that can detect 12 common cancers to be trialled on NHS

Published on May 13, 2025

The "PanSeer" blood test, developed by biotech company Singlera Genomics, is designed to identify early signs of cancers — including bowel, lung, liver, and ovarian — before symptoms even appear.

Now, this innovative test is set to be trialled on 140,000 people across England, marking one of the most ambitious early-detection studies the NHS has ever run.

🔍 Why does it matter?
Early detection can make the difference between treatable and untreatable. If successful, this test could dramatically reduce late-stage diagnoses, shorten treatment times, and ultimately save lives — especially in hard-to-detect cancers.

It’s also another strong signal that the UK is embracing tech-powered healthcare innovation at scale.

🔗 Read the full story on Sky News:
https://news.sky.com/story/amp/blood-test-that-can-detect-12-common-cancers-to-be-trialled-on-nhs-13354165

Other news

Revolutionary tech promises to transform life-saving antibody treatments and reduce hospital stays

May 13, 2025
A major step forward in antibody treatment has just come out of the University of Bath. 🧪Researchers have developed a revolutionary new technology that could completely change how antibody-based drugs are made — making them more effective, faster to produce, and potentially much more accessible.This matters because antibody treatments are crucial for fighting serious illnesses like cancer and aut

Graduate entrepreneurs release period cup cleaning case

May 13, 2025
Kira Goode and Monica Wai, two graduates from the University of Bristol’s Centre for Innovation and Entrepreneurship, have launched a product designed to make sustainable period care more practical and inclusive.Their startup, Eleria, has just released a portable menstrual cup cleaning and sterilisation case — a compact, discreet solution to a key barrier preventing many from switching to reusable